Markus Puhlmann

Markus Puhlmann appears in our data through filings on Perspective Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 15 December 2023 to 24 January 2024, the count stands at 4 filings.

On the market, this insider has only ever bought: 4 purchases, €301k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2024 to date brings 1 purchase and no sales.

The median purchase comes to €79k. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +229.4%. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 26 January 2024, reports an open-market purchase of €129k in Perspective Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.